Gland Pharma Limited

NSE GLAND.NS

Gland Pharma Limited Receivables for the year ending March 31, 2024: USD 197.60 M

Gland Pharma Limited Receivables is USD 197.60 M for the year ending March 31, 2024, a 69.41% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.
  • Gland Pharma Limited Receivables for the year ending March 31, 2023 was USD 116.64 M, a -26.79% change year over year.
  • Gland Pharma Limited Receivables for the year ending March 31, 2022 was USD 159.32 M, a 73.86% change year over year.
  • Gland Pharma Limited Receivables for the year ending March 31, 2021 was USD 91.63 M, a 14.75% change year over year.
  • Gland Pharma Limited Receivables for the year ending March 31, 2020 was USD 79.86 M, a 9.65% change year over year.
Key data
Date Receivables Inventory Goodwill Total Assets
Market news
Loading...
SV Wall Street
NSE: GLAND.NS

Gland Pharma Limited

CEO Mr. Shyamakant Giri
IPO Date Nov. 20, 2020
Location India
Headquarters Plot No. 11 & 84, TSIIC Phase: IV
Employees 4,217
Sector Healthcare
Industries
Description

Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, pain management, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, orthopedics, hematinic, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business to business in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd.

Similar companies

CAMS.NS

Computer Age Management Services Limited

USD 41.53

-1.00%

LALPATHLAB.NS

Dr. Lal PathLabs Limited

USD 32.88

-0.93%

ROUTE.NS

Route Mobile Limited

USD 13.80

0.71%

LAURUSLABS.NS

Laurus Labs Limited

USD 6.73

-0.82%

ALKEM.NS

Alkem Laboratories Limited

USD 58.36

0.18%

StockViz Staff

February 2, 2025

Any question? Send us an email